REFERENCES
- Isotalo PA, Wells GA, Donnelly JG. Neonatal and fetal methylenetetrahydrofolate reductase genetic polymorphisms: an examination of C677T and A1298C mutations. Am J Hum Genet. 2000;67:986–990.
- Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost. 2005;3:292.
- Alioglu B, Ozyurek E, Tarcan A, Atac FB, Gurakan B, Ozbek N. Heterozygous methylenetetrahydrofolate reductase 677C-T gene mutation with mild hyperhomocysteinemia associated with intrauterine ileofemoral artery thrombosis. Blood Coagul Fibrinolysis. 2006;17:495–498.
- Petäjä J, Manco-Johnson MJ. Protein C pathway in infants and children. Semin Thromb Hemostasis. 2003;29:349–361.
- Johnson JM, Knapp-Clevenger R. Activated protein C concentrate reverses purpura fulminans in severe genetic protein C deficiency. J Pediatr Hematol Oncol. 2004;26:25–27.
- Kafalı G, Tanzer F, Yıldız E. Neonatal purpura fulminans due to homozygous protein C deficiency. J Tropical Pediatr. 1998;44:122–123.
- Tureboylu R, Salis R, Erbe R, Martin D, Lakshminrusimha S, Ryan RM. Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis. J Perinatol. 2007;27:490–495.
- Zhu BT. On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis. Histol Histopathol. 2002;17:1283–1291.